Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 239

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer

Open access
Chen, Chun‐Liang, Mahalingam, Devalingam, Osmulski, Pawel, Jadhav, Rohit R., Wang, Chiou‐Miin, Leach, Robin J., Chang, Tien‐Cheng, Weitman, Steven D., Kumar, Addanki Pratap, Sun, LuZhe, Gaczynska, Maria E., Thompson, Ian M., Huang, Tim Hui‐Ming · 2013 · The Prostate

Abstract

BACKGROUND: Prostate tumors shed circulating tumor cells (CTCs) into the blood stream. Increased evidence shows that CTCs are often present in metastatic prostate cancer and can be alternative sources for disease profiling and prognostication. Here we postulate that CTCs expressing genes related to epithelial–mesenchymal transition (EMT) are strong predictors of metastatic prostate cancer. METHODS: A microfiltration system was used to trap CTCs from peripheral blood based on size selection of large epithelial‐like cells without CD45 leukocyte marker. These cells individually retrieved with a micromanipulator device were assessed for cell membrane physical properties using atomic force microscopy. Additionally, 38 CTCs from eight prostate cancer patients were used to determine expression profiles of 84 EMT‐related and reference genes using a microfluidics‐based PCR system. RESULTS: Increased cell elasticity and membrane smoothness were found in CTCs compared to noncancerous cells, highlighting their potential invasiveness and mobility in the peripheral circulation. Despite heterogeneous expression patterns of individual CTCs, genes that promote mesenchymal transitioning into a more malignant state, including IGF1, IGF2, EGFR, FOXP3, and TGFB3, were commonly observed in these cells. An additional subset of EMT‐related genes (e.g., PTPRN2, ALDH1, ESR2, and WNT5A) were expressed in CTCs of castration‐resistant cancer, but less frequently in castration‐sensitive cancer. CONCLUSIONS: The study suggests that an incremental expression of EMT‐related genes in CTCs is associated with metastatic castration‐resistant cancer. Although CTCs represent a group of highly heterogeneous cells, their unique EMT‐related gene signatures provide a new opportunity for personalized treatments with targeted inhibitors in advanced prostate cancer patients. Prostate 73: 813–826, 2013. © 2012 Wiley Periodicals, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pros.22625

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 239

Metadata

Authors
Chen, C., Mahalingam, D., Osmulski, P., Jadhav, R. R., Wang, C., Leach, R. J., Chang, T., Weitman, S. D., Kumar, A. P., Sun, L., Gaczynska, M. E., Thompson, I. M., & Huang, T. H.
Venue
The Prostate
Publisher
Wiley
Published
2012-12-31
Volume
73
Issue
8
Pages
813-826
ISSN
  • 0270-4137 (ISSN-L)
  • 1097-0045
OpenAlex
W2023771000
Cited by
239
References
5
FWCI
13.99
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer. https://app.cochat.ai/papers/10.1002/pros.22625
The paper
Chen, C., Mahalingam, D., Osmulski, P., Jadhav, R. R., Wang, C., Leach, R. J., Chang, T., Weitman, S. D., Kumar, A. P., Sun, L., Gaczynska, M. E., Thompson, I. M., & Huang, T. H. (2013). Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer. The Prostate. https://doi.org/10.1002/pros.22625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.